World Stem Cell Markets Analyzed in New Report Published at MarketPublishers.com
11 Jan 2012 • by Natalie Aster
LONDON – With the potential of replacing defective or damaged cells resulting from disorders and injuries, stem cells are of great interest, leading to a variety of new regenerative therapies. Also, in vitro study of stem cells would offer the possibility for scientists to learn more about the function of various organs and the course of particular diseases, with stem cells to ultimately permit drug developers to test emerging therapies on diseased cells.
New research report “Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development” prepared by Kalorama Information has been recently published by Market Publishers Ltd.
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Published: January, 2012
Price: US$ 3.995,00
The research report provides the best, moderate and worst case scenarios for the three key markets for stem cells: stem cells in drug development, stem cells in cord blood banking, stem cell therapeutics. Stem cell therapeutics potentials are also provided broken down by disease.
Trends discussed in the report are as follows:
- ethical questions;
- U.S. – state and federal initiatives;
- research funding
- cord blood initiatives;
- international initiatives;
- stem cell patents;
- other healthcare regulations.
More new research reports by the publisher can be found at Kalorama Information page.